SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-15-073236
Filing Date
2015-03-02
Accepted
2015-03-02 16:05:44
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A d867094d10qa.htm 10-Q/A 740343
2 EX-31.1 d867094dex311.htm EX-31.1 8725
3 EX-31.2 d867094dex312.htm EX-31.2 9083
4 EX-32.1 d867094dex321.htm EX-32.1 3299
5 EX-32.2 d867094dex322.htm EX-32.2 3719
  Complete submission text file 0001193125-15-073236.txt   8841567

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT slxp-20140331.xml EX-101.INS 1091050
7 XBRL TAXONOMY EXTENSION SCHEMA slxp-20140331.xsd EX-101.SCH 79318
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE slxp-20140331_cal.xml EX-101.CAL 81130
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE slxp-20140331_def.xml EX-101.DEF 357395
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE slxp-20140331_lab.xml EX-101.LAB 578963
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE slxp-20140331_pre.xml EX-101.PRE 476614
Mailing Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615
Business Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615 (919) 862-1000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-23265 | Film No.: 15664541
SIC: 2834 Pharmaceutical Preparations